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and Lysosomal Storage DiseasesTo the Editor,
We thank the author for his comments focusing on the wide
range of incidence (1e18%) of nonimmune hydrops fetalis
(NIHF) due to inherited metabolic diseases, including lyso-
somal storage diseases (LSDs). This wide range of incidence
may arise from many reasons as discussed below.
First of all, in developed western countries, the low
incidence of inherited metabolic diseases because of
infrequent consanguineous marriages is expected to be the
real cause of low incidences. Additionally, in developed
countries, the low index of clinical suspicion because of the
inadequate clinical experience of physicians may cause a
pseudo-reduction in the incidence. However, in developing
countries, the low index of clinical suspicion or lack of
appropriate diagnostic laboratory technologies, and finan-
cial and technical problems in sending biological specimens
of the cases to referral centers in developed countries and
getting the diagnoses may cause a pseudo-reduction in the
incidence. More importantly, severe cases may be lost by
abortions or early intrauterine deaths during the prenatal
period, with the result that they could not receive detailed
investigation and diagnosis. All these factors could
contribute to low incidence of NIHF due to LSDs.DOI of original article: http://dx.doi.org/10.1016/
j.pedneo.2013.08.003.
1875-9572/$36 Copyright ª 2013, Taiwan Pediatric Association. Publish
http://dx.doi.org/10.1016/j.pedneo.2013.08.002On the other hand, high incidence of NIHF due to LSDs
could be caused by the high incidence of consanguineous
marriages and inherited metabolic diseases in developing
countries. However, in developed countries, owing to
referral centers receiving patients and biological specimens
from all over the world, the incidence is expected to be
high. Therefore, it is very difficult to calculate the real
incidence of such rare inherited metabolic diseases globally,
and a high index of clinical suspicion supported by appro-
priate laboratory investigations to establish the diagnosis
should be more important than calculating the incidence.Ozge Surmeli-Onay*
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